London, July 7, 2020 – LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced a publication in Contemporary Clinical Trials1, which details the design for “A Prospective,… Read More
VANCOUVER, British Columbia, July 8, 2020, –(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that it and longtime partner, Merck (known as MSD… Read More
Lab2Launch entrepreneurship@UBC’s Lab2Launch venture building program is for UBC researchers and scientists who are focusing on the development of a scientific or technological innovation which is unique, proprietary and difficult to reproduce,… Read More
On behalf of the Board of Directors and staff, I am pleased to share with you a copy of the Genome British Columbia Annual Report for the fiscal year 2019/2020, celebrating… Read More
Vancouver, BC – July 7, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and… Read More
